Tempus AI, Inc.

NasdaqGS:TEM Stock Report

Market Cap: US$9.9b

Tempus AI Future Growth

Future criteria checks 1/6

Tempus AI is forecast to grow earnings and revenue by 50.7% and 17.6% per annum respectively. EPS is expected to grow by 47.5% per annum. Return on equity is forecast to be 16.9% in 3 years.

Key information

50.7%

Earnings growth rate

47.54%

EPS growth rate

Life Sciences earnings growth15.6%
Revenue growth rate17.6%
Future return on equity16.87%
Analyst coverage

Good

Last updated25 Feb 2026

Recent future growth updates

Recent updates

Tempus AI: No AI Interruption Detected

Feb 25

Genomics And AI Data Licensing Will Transform Long Term Oncology Outcomes

Catalysts About Tempus AI Tempus AI operates a genomics and data platform focused on Oncology and related clinical insights. What are the underlying business or industry changes driving this perspective?

After Leaping 29% Tempus AI, Inc. (NASDAQ:TEM) Shares Are Not Flying Under The Radar

Oct 09
After Leaping 29% Tempus AI, Inc. (NASDAQ:TEM) Shares Are Not Flying Under The Radar

Tempus AI, Inc. (NASDAQ:TEM) Looks Just Right With A 28% Price Jump

Aug 15
Tempus AI, Inc. (NASDAQ:TEM) Looks Just Right With A 28% Price Jump
User avatar

AstraZeneca And Pathos Partnership Will Expand Precision Medicine

Pharma partnerships and the shift toward AI-driven precision medicine are fueling strong, high-margin revenue growth and expanding Tempus' competitive opportunities.

The Tempus AI, Inc. (NASDAQ:TEM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 09
The Tempus AI, Inc. (NASDAQ:TEM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Tempus: The AI Engine Powering Healthcare

Apr 20

Is Tempus AI (NASDAQ:TEM) A Risky Investment?

Mar 25
Is Tempus AI (NASDAQ:TEM) A Risky Investment?

Tempus AI's Valuation Bakes In Strong Growth - A Hold For Now

Mar 25

Tempus AI: The Investment Opportunity Of A Decade, Strong Buy

Mar 18

Tempus AI Earnings: A Promising Business, But There Are Risks

Feb 25

Tempus AI Is A Buy On Dips In The AI-Driven Healthcare Sector

Feb 18

Tempus AI: In Vogue, But Better To Wait For Some Retracement

Feb 05

Tempus AI: Don't Be Blindly Optimistic On Anything AI

Jan 28

Tempus AI: Why I'm Avoiding This Stock In 2025

Jan 21

Tempus AI: Recent Weakness Presents Gift Ahead Of The Holidays

Dec 18

Tempus AI: Why I'm Buying This AI Stock

Dec 08

Earnings and Revenue Growth Forecasts

NasdaqGS:TEM - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20282,302-531372279
12/31/20271,940-1783910014
12/31/20261,594-301-401813
12/31/20251,272-245-245-218N/A
9/30/20251,105-204-249-221N/A
6/30/2025952-200-73-52N/A
3/31/2025803-721-213-193N/A
12/31/2024693-745-211-189N/A
9/30/2024640-801-207-190N/A
6/30/2024596-790-325-292N/A
3/31/2024562-293-284-249N/A
12/31/2023532-254-249-214N/A
9/30/2023485-276-266-233N/A
12/31/2022321-334-187-168N/A
9/30/2022293-325-192-173N/A
12/31/2021258-298-224-212N/A
9/30/2021285-296-205-193N/A
6/30/2021284-286-199-188N/A
3/31/2021236-270-209-198N/A
12/31/2020188-254-220-207N/A
12/31/201962-148-134-117N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TEM is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TEM is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TEM is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TEM's revenue (17.6% per year) is forecast to grow faster than the US market (10.3% per year).

High Growth Revenue: TEM's revenue (17.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: TEM's Return on Equity is forecast to be low in 3 years time (16.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/27 16:57
End of Day Share Price 2026/02/26 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tempus AI, Inc. is covered by 21 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Michael RyskinBofA Global Research
Mark MassaroBTIG